CURE® TV

With CURE TV®, you have access to a variety of informative and uplifting videos. You’ll find interviews with cancer experts, advocates, patients, caregivers, as well as highlights from our celebratory events showcasing interviews with award winners and celebrity speakers.

MPN Hero Bridges the Care Gap to Address Mental Health Issues in Patients with MPNs

January 11th 2020, 3:00am

Video

Madeleine Henriquez noticed that the mental health care of patients with MPN was being overlooked and took action in a way that has changed her community for the better.

BTK Inhibitor Use Proves Beneficial in Mantle Cell Lymphoma Treatment

January 8th 2020, 12:00am

Video

Typically, the longer a patient with cancer is exposed to a drug the more side effects they experience, but in the case of Imbruvica, the opposite appears to be true for patients with MCL.

MPN Hero Advocates For Individualized Patient Care

January 6th 2020, 7:00pm

Video

Patients with rare blood cancers are not all the same, and this understanding has helped Dr. Irum Khan become an advocate for people with these conditions — and an MPN Hero.

Limiting Treatment Duration Improves Cost Effectiveness in CLL

January 5th 2020, 8:00pm

Video

Researchers are exploring ways to limit the duration of treatment in chronic lymphocytic leukemia in order to reduce costs.

Patients with Breast Cancer Who Face Treatment Disparities Grow Their Role at Major Medical Conference

December 26th 2019, 7:19pm

Video

Young women and women of color with breast cancer, as well as those with metastatic disease, had the chance to experience SABCS 2019 and advocate for representation of their patient groups in ongoing clinical trials.

HER2+ mBC: DESTINY-Breast04 Trial

December 25th 2019, 12:00am

Video

The comparison of trastuzumab deruxtecan (DS-8201a) with standard chemotherapy is examined for patients with low levels of HER2 metastatic breast cancer and final thoughts on the future treatment landscape of HER2+ breast cancer.

Treating HER2-Positive Metastatic Breast Cancer: DESTINY-Breast02 and DESTINY-Breast03

December 22nd 2019, 8:00pm

Video

The role of antibody drug conjugate DS-8201a (trastuzumab deruxtecan) in the treatment of HER2-positive metastatic breast cancer and an overview of the DESTINY-Breast02 and DESTINY-Breast03 trials.

Management of HER2 Expression in Breast Cancer

December 20th 2019, 7:01pm

Video

Ian E. Krop, MD, PhD, provides insight on HER2 expression in breast cancer, treatment for blocking HER2, and the management of newly diagnosed HER2+ metastatic breast cancer with T-DM1.

Ibrance Shows Promise in Patients with Brain Metastases Who Harbor a CDK Pathway Alteration

December 19th 2019, 3:00am

Video

New findings show that Ibrance has the potential to help patients with brain metastases that harbor a CDK pathway alteration.

Education and Teamwork Are Key in the Treatment of MPNs

December 16th 2019, 11:00pm

Video

At the 2019 MPN Heroes® event Tammy Matuska, B.S.N., RN, known as the "lifeline to patients," was honored for her outstanding work for patients with MPN.